XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -0.19%43.67B | -0.19%43.67B | 9.75%49.72B | 13.75%47.83B | 9.64%51.5B | 39.99%43.76B | 39.99%43.76B | 79.13%45.3B | 88.98%42.05B | 73.43%46.97B |
-Cash and cash equivalents | -0.15%43.23B | -0.15%43.23B | 9.87%49.3B | 9.18%45.41B | 9.71%51.03B | 40.32%43.3B | 40.32%43.3B | 80.25%44.87B | 92.99%41.6B | 73.53%46.51B |
-Restricted cash and investments | -3.71%441M | -3.71%441M | -3.22%421M | 434.29%2.42B | 3.04%474M | 14.50%458M | 14.50%458M | 9.02%435M | -35.15%452M | 63.70%460M |
Receivables | 2.18%2.53B | 2.18%2.53B | 4.37%2.58B | 8.58%2.49B | 11.73%2.51B | 17.78%2.48B | 17.78%2.48B | 33.24%2.47B | 42.58%2.3B | 52.13%2.25B |
-Accounts receivable | 2.18%2.53B | 2.18%2.53B | 4.37%2.58B | 8.58%2.49B | 11.73%2.51B | 17.78%2.48B | 17.78%2.48B | 33.24%2.47B | 42.58%2.3B | 52.13%2.25B |
Net loan | 1.86%311.72B | 1.86%311.72B | 1.08%303.81B | 1.50%302.35B | 2.21%301.41B | 2.25%306.03B | 2.25%306.03B | 2.42%300.57B | 4.24%297.89B | 9.09%294.88B |
-Gross loan | 2.07%327.98B | 2.07%327.98B | 1.53%320.34B | 2.07%318.99B | 2.45%316.79B | 2.81%321.33B | 2.81%321.33B | 3.22%315.52B | 5.14%312.53B | 9.79%309.2B |
-Allowance for loans and lease losses | 6.29%16.26B | 6.29%16.26B | 10.56%16.53B | 13.68%16.65B | 7.42%15.38B | 15.53%15.3B | 15.53%15.3B | 22.49%14.96B | 27.46%14.65B | 26.62%14.32B |
Securities and investments | 4.92%83.01B | 4.92%83.01B | 11.58%83.5B | 1.07%79.25B | -4.31%78.4B | 2.86%79.12B | 2.86%79.12B | -0.62%74.84B | -5.55%78.41B | -8.03%81.93B |
-Available for sale securities | ---- | ---- | 9.11%79.31B | -3.57%74.44B | -6.67%75.64B | --76.65B | --76.65B | -2.94%72.68B | -1.81%77.2B | -2.29%81.04B |
-Short term investments | 3,262.21%83.01B | 3,262.21%83.01B | 94.80%4.19B | 295.88%4.81B | 212.33%2.76B | -96.79%2.47B | -96.79%2.47B | 417.55%2.15B | -72.40%1.21B | -85.59%884M |
Net PPE | 3.11%4.51B | 3.11%4.51B | 1.42%4.44B | 0.85%4.4B | 0.02%4.37B | 0.55%4.38B | 0.55%4.38B | 2.65%4.38B | 2.86%4.36B | 3.00%4.37B |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 2.15%9.56B | 2.15%9.56B | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -3.54%-5.18B | -3.54%-5.18B | ---- | ---- | ---- |
Goodwill and other intangible assets | -0.04%15.06B | -0.04%15.06B | 0.23%15.08B | 0.01%15.06B | 1.91%15.06B | 1.95%15.07B | 1.95%15.07B | 1.88%15.05B | 1.91%15.06B | -0.03%14.78B |
-Goodwill | -0.04%15.06B | -0.04%15.06B | 0.23%15.08B | 0.01%15.06B | 1.91%15.06B | 1.95%15.07B | 1.95%15.07B | 1.88%15.05B | 1.91%15.06B | -0.03%14.78B |
Other assets | 7.22%29.64B | 7.22%29.64B | -5.28%27.31B | 3.27%28.64B | 7.50%28.47B | 4.13%27.64B | 4.13%27.64B | -1.55%28.83B | -3.09%27.74B | -2.69%26.49B |
Total assets | 2.44%490.14B | 2.44%490.14B | 3.18%486.43B | 2.61%480.02B | 2.13%481.72B | 5.10%478.46B | 5.10%478.46B | 6.12%471.44B | 6.25%467.8B | 8.63%471.66B |
Liabilities | ||||||||||
Total deposits | 4.10%362.71B | 4.10%362.71B | 2.20%353.63B | 2.25%351.44B | 0.33%350.97B | 4.63%348.41B | 4.63%348.41B | 9.09%346.01B | 11.63%343.71B | 11.61%349.83B |
Federal funds purchased and securities sold under agreement to repurchase | 4.46%562M | 4.46%562M | -0.38%520M | 10.17%715M | 4.80%568M | -39.07%538M | -39.07%538M | -93.50%522M | -94.07%649M | -8.75%542M |
Payables | 2.62%666M | 2.62%666M | 2.92%705M | 4.87%668M | 22.71%762M | 23.15%649M | 23.15%649M | 58.20%685M | 91.29%637M | 137.93%621M |
-Accounts payable | 2.62%666M | 2.62%666M | 2.92%705M | 4.87%668M | 22.71%762M | 23.15%649M | 23.15%649M | 58.20%685M | 91.29%637M | 137.93%621M |
Long term debt and capital lease obligation | -8.78%44.99B | -8.78%44.99B | 0.19%48.82B | -4.77%47.24B | 3.23%49.79B | 3.11%49.32B | 3.11%49.32B | 4.61%48.73B | 3.36%49.61B | 7.75%48.24B |
-Long term debt | -8.78%44.99B | -8.78%44.99B | 0.19%48.82B | -4.77%47.24B | 3.28%49.79B | 3.11%49.32B | 3.11%49.32B | 4.69%48.73B | 3.45%49.61B | 7.70%48.21B |
-Long term capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --24M |
Other liabilities | -4.76%20.44B | -4.76%20.44B | -9.11%19.84B | 17.86%21.97B | 22.75%21.83B | 5.01%21.46B | 5.01%21.46B | 3.25%21.82B | -5.48%18.64B | -5.42%17.78B |
Total liabilities | 2.14%429.36B | 2.14%429.36B | 1.37%423.51B | 2.13%422.04B | 1.66%423.92B | 4.40%420.38B | 4.40%420.38B | 6.20%417.77B | 6.81%413.24B | 10.36%417.01B |
Shareholders'equity | ||||||||||
Share capital | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M |
-common stock | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M | 0.00%7M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 2.50%36.43B | 2.50%36.43B | 2.50%36.22B | 2.41%36.01B | 2.45%35.81B | 2.35%35.54B | 2.35%35.54B | 2.18%35.33B | 2.14%35.16B | 1.94%34.95B |
Retained earnings | 5.84%64.51B | 5.84%64.51B | 5.24%63.7B | 5.39%62.21B | 6.92%61.91B | 6.58%60.95B | 6.58%60.95B | 7.63%60.53B | 7.64%59.03B | 9.04%57.9B |
Less: Treasury stock | 2.44%30.87B | 2.44%30.87B | 2.44%30.71B | 2.44%30.55B | 2.43%30.39B | 2.44%30.14B | 2.44%30.14B | 2.45%29.98B | 3.04%29.82B | 10.05%29.66B |
Gains losses not affecting retained earnings | -12.31%-9.29B | -12.31%-9.29B | 48.57%-6.29B | 1.19%-9.7B | -11.64%-9.53B | 16.62%-8.27B | 16.62%-8.27B | -14.20%-12.22B | -41.96%-9.82B | -108.65%-8.54B |
Total stockholders'equity | 4.64%60.78B | 4.64%60.78B | 17.25%62.93B | 6.27%57.98B | 5.76%57.8B | 10.47%58.09B | 10.47%58.09B | 5.52%53.67B | 2.15%54.56B | -3.00%54.65B |
Total equity | 4.64%60.78B | 4.64%60.78B | 17.25%62.93B | 6.27%57.98B | 5.76%57.8B | 10.47%58.09B | 10.47%58.09B | 5.52%53.67B | 2.15%54.56B | -3.00%54.65B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |